balance 2,3% glükóz 1,75 mmol/l kalcium peritoneális dializáló oldat, 1500 ml
fresenius medical care deutschland gmbh - electrolits - hypertonic solutions
balance 2,3% glükóz 1,75 mmol/l kalcium peritoneális dializáló oldat, 2500 ml
fresenius medical care deutschland gmbh - electrolits - hypertonic solutions
balance 4,25% glükóz 1,75 mmol/l kalcium peritoneális dializáló oldat, 1500 ml
fresenius medical care deutschland gmbh - electrolits - hypertonic solutions
balance 4,25% glükóz 1,75 mmol/l kalcium peritoneális dializáló oldat, 2000 ml
fresenius medical care deutschland gmbh - electrolits - hypertonic solutions
balance 4,25% glükóz 1,75 mmol/l kalcium peritoneális dializáló oldat, 2500 ml
fresenius medical care deutschland gmbh - electrolits - hypertonic solutions
egilok xr 25 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
egilok xr 50 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
egilok xr 100 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
egilok xr 200 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol-fumarát dihidrát, glycopyrronium-bromid - tüdőbetegség, krónikus obstruktív - gyógyszerek obstruktív légúti betegségek, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.